tisagenlecleucel
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for tisagenlecleucel, covering 2020-07-09 to 2024-05-29. Get the full timeline:
Most recent: Clinical Trial Update: Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence [Phase 1, Phase 2]